COVID-19

Technion researchers are on the frontline in the fight against COVID-19 and have mobilized in the worldwide effort to find solutions for the current global health crisis.

Researchers in more than 45  Technion labs are working round the clock to help fight the spread of COVID-19. Their research includes early detection and diagnosis of the virus, development of a vaccine and therapies, and designing robotic solutions for remote monitoring and care of patients.

“Technion is at the forefront of science and technology worldwide, and during this time of crisis, we are collaborating closely with the health system and the hospitals in order to find immediate solutions to the challenges they are facing,” said Technion President Prof. Uri Sivan. “We are working on advanced diagnostic techniques, personalized medical treatment, technologies that enable pinpointed drug delivery, treatment protocols based on machine learning and artificial intelligence, data mining and Big Data management, developing robots for remote medical care, and more. Technion’s added value is apparent in the close interaction between medicine and engineering at our university, and in the interdisciplinary collaborations that are generating rapid and sophisticated solutions to help fight COVID-19.”

SUPPORT THE EMERGENCY RESEARCH FUND

STAY UP TO DATE ON COVID-19 RESEARCH NEWS AND UPDATES FROM THE TECHNION

DIAGNOSTICS

  • Saliva-based microscale diagnostics I Prof. Moran Bercovici I Mechanical Engineering*
  • Monitoring the sewage system for COVID-19 residue to track the spread of the virus I Prof. Eran Friedler I Civil and Environmental Engineering*
  • Mathematical model with user interface for epidemiological analysis of COVID-19 epidemic I Prof. Nir Gavish I Mathematics*
  • Rapid testing kit for COVID-19 diagnosis I Prof. Naama Geva-Zatorsky I Medicine*
  • Diagnostic test for pre-symptomatic COVID-19 carriers I Prof. Hossam Haick I Chemical Engineering
  • Pooling method for accelerated testing of COVID-19 I Prof. Roy Kishony I Biology*
  • Genetic changes in COVID-19 patients over time as a tool for predicting disease progression I Prof. Yael Mandel-Gutfreund I Biology
  • Using AI to evaluate a patient’s condition I Profs. Shie Mannor, Uri Shalit, Joachim Behar I Electrical Engineering, Industrial Engineering and Management, Biomedical Engineering
  • Identifying and quantifying RNA using nanopores I Prof. Amit Meller I Biomedical Engineering
  • Sensor for rapid COVID-19 diagnosis using CRISPR technology I Prof. Daniel Ramez I Biomedical Engineering
  • Thermal imaging camera for remote measurement of vital signs I Prof. Yonatan Savir I Medicine*
  • Advanced microscopy techniques to detect COVID-19 antibodies in the blood I Prof.  Yoav Shechtman I Biomedical Engineering
  • Monitoring the immune status and identifying high-risk patients I Prof. Shai Shen-Orr I Medicine*
  • Diagnostic testing based on throat cultures and blood and urine samples I Prof. Tomer Shlomi I Computer Science
  • Non-invasive blood test to diagnose COVID-19 patients I Prof. Dvir Yelin I Biomedical Engineering
  • Rapid and accurate diagnostic techniques I Prof. Gilad Yossifon and Prof. Yehezkel Kashi I Mechanical Engineeing, Biotechnology and Food Engineering
  • AI powered smart stethoscope I Prof. Yehoshua Zeevi and Prof. Rafael Beyar I Electrical Engineering, Medicine
  • Virology collaborative research lab I Prof. Yotam Bar-On I Medicine

VACCINE DEVELOPMENT

THERAPEUTICS

  • ACE-2 receptor based therapies for COVID-19 I Prof. Zaid Abassi I Medicine*
  • Ointment COVID-19 infections I Prof. Roee Amit I Biotechnology and Food Engineering
  • Respirators using microturbines I Prof. Beni Cukurel I Aerospace Engineering
  • Drug development I Prof. Zeev Gross I Chemistry
  • COVID-19 patient breathing patterns: Interaction between respiratory, heart and cardiovascular systems I Prof. Amir Landsberg I Biomedical Engineering
  • Trapping COVID-19 using existing nano-ghost technology I Prof. Marcelle Machluf I Biotechnology and Food Engineering
  • Characterizing cannabinoids to inhibit the cytokine storm and suppress the ACE-2 receptor I Prof. David Meiri I Biology
  • Targeted drug delivery for ARDS I Prof. Avi Schroeder I Chemical Engineering
  • Direct drug delivery to the lungs I Prof. Dror Seliktar I Biomedical Engineering
  • Drug development for rapid healing of damaged tissue I Prof. Yuval Shaked I Medicine
  • Liquid Foam Therapy (LIFT) for ARDS I Prof. Josué Sznitman I Biomedical Engineering*
  • Heparin-like drugs to inhibit COVID-19 infection and its progression I Prof. Israel Vlodavsky I Medicine

AIDS FOR MEDICAL TEAMS

  • Ultrasound for lung imaging I Prof. Alex Bronstein, Prof. Ron Kimmel and Doron Shaked I Computer Science
  • Durable surface disinfectant I Prof. Yachin Cohen I Materials Science and Engineering
  • 2D and 3D biocidal surfaces I Prof. Yoav Eichen I Chemistry
  • Active coating for protective masks I Prof. Yair Ein-Eli I Materials Science and Engineering
  • Antiviral disinfectants I Prof. Shady Farah I Chemical Engineering*
  • Analysis of antiviral disinfectants I Prof. Debbie Lindell and Prof. Oded Beja I Biology
  • Photocatalytic antiviral disinfectant I Prof. Yaron Paz I Chemical Engineering
  • Antiviral coating I Prof. Boaz Pokroy I Materials Science and Engineering
  • Air Shield innovative protective equipment for medical personnel I Prof. Ezri Tarazi I Architecture and Town Planning *
  • Antiviral protective sticker “Maya” using nanometric fibers I Prof. Eyal Zussman I Mechanical Engineering *

*Advanced stage


Community is Immunity - A Message from Technion President Prof. Uri Sivan

TRANSCRIPT: Message from Technion President, Prof. Uri Sivan
Haifa, 17th March 2020

At this moment, COVID-19 is threatening our families, communities and wellbeing worldwide. Its rapid spread affects our normal lives and jeopardizes our inherent need for certainty and security. In these difficult times, our hearts and thoughts are with those who lost their dear ones, those infected by the virus and their families, and those confined to their premises.

For all of us, the atmosphere is unsettling. But my own experience tells me that if handled correctly, by focusing first on saving lives and on containing the danger, such crises may eventually turn into a source of strength and insight.

At Technion, we are currently focusing on the containment phase, taking all necessary steps to keep the Technion family safe.

Following instructions by the Israel Ministry of Health, we will open the spring semester on March 18th with all classes taught online. Residents in self-isolation in our student dorms have been moved to one wing for effective monitoring and are provided with food and other supplies by our Students Association. We are also maintaining close communication with all the Technion community, recognizing the strength and resilience that emerges when we work together for the safety of each other. At Technion, we believe that community is immunity. Together, we will emerge stronger from this crisis.

COVID-19 is a global challenge, which ultimately asks for global scientific and technological solutions. At Technion we have already started to direct the brainpower of our faculty to addressing these challenges. In the long-term, one effect of COVID-19 on Technion will be an intensification of research in multidisciplinary fields which address the threat of epidemics and pandemics. These include medical research, pharmaceuticals, big data, artificial intelligence, advanced manufacturing, digital health responses, and much more.

Dear Technion family across the world, we wish you good health, safety and well-being. We will emerge from COVID19 together with insight, strength and resilience.